SAUDI-ECONOMY-PLANNING
19.1.2023 18:27:35 CET | Business Wire | Press release
Saudi Arabia’s Ministry of Economy and Planning (MEP) in collaboration with UpLink today launched an innovation challenge designed to crowdsource transformative solutions to enhance food security in countries impacted by low rainfall, drought, and desertification.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230119005599/en/
Saudi's Ministry of Economy and Planning and UpLink launch innovation challenge to enhance food security. (Photo: AETOSWire)
MEP and UpLink, the World Economic Forum’s (WEF) open innovation platform, made the announcement at the Forums’ 2023 Annual Meeting in Davos as part of Saudi Arabia’s efforts to develop innovative solutions to the world’s most critical challenges, through collaboration and cooperation.
The Food Ecosystems and Arid Climates Challenge is a global call for food entrepreneurs, start-ups, social ventures, and small-medium sized enterprises to submit solutions that incorporate low or high technologies. The winning cohort will be eligible to access CHF100,000 to scale and implement their venture in regions with arid climates, while enhancing their visibility and access to networking opportunities. This is the first of two challenges focused on food systems, with a second to be launched later in 2023 on climate-smart agriculture.
Announcing the challenge at a press conference, His Excellency Faisal F. Alibrahim, Minister of Economy and Planning for the Kingdom of Saudi Arabia, said: “Our world faces a wide range of major socioeconomic challenges, and food security is at the top of the list.
“The Kingdom of Saudi Arabia is fully committed to being a major innovation accelerator, and dedicating resources to empower and support entrepreneurs who are determined to tackle the challenge of food security, in this case in regions with arid climates.”
Around 828 million people today are hungry, while 2.3 billion are food insecure. Furthermore, 3.1 billion people globally cannot afford a healthy diet and it is estimated that 700 million will be displaced by drought by 2030.
The challenge aims to strengthen food security and improve the supply of healthy and nutritious foods in arid regions by supporting solutions with a strong socioeconomic, environmental and educational impact to strengthen local food value chains.
With the support of government-led initiatives such as the Food Ecosystems and Arid Climates Challenge, it brings us closer to meeting Sustainable Development Goal (SDG) 2, Zero Hunger by 2030.
To drive a whole-of-government approach that achieves the 17 SDGs, MEP established and leads the Sustainable Development Steering Committee, which coordinates government efforts across the 2030 SDG Agenda.
Since the establishment of the Sustainable Development Steering Committee (SDSC), a governance structure has been operationalized and chaired by His Excellency Faisal Alibrahim and includes 20 senior stakeholders from various government entities to oversee Saudi Arabia's SDG Agenda.
Saudi Arabia is participating in the Annual Meeting 2023 (AM23) of the World Economic Forum in Davos between 16-20 January to bridge global divides and facilitate near-term stability while driving multilateral reform and long-term transformation.
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230119005599/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release
Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere
The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 11:00:00 CEST | Press release
The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport. Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping. Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027. The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that e
Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 11:00:00 CEST | Press release
Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkb
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
